You searched for oncology.
Page 4 of 344 results
Impact of Precision Medicine on Oncology Field
Precision medicine is changing how physicians think about treatments, with great advances coming out of the oncology field. In podcast No. 42, three CHOC experts and speakers at the upcoming Peds2040 conference.
2018 CHOC Oncology Prom
The annual CHOC Oncology Prom aims to make teen cancer patients' dreams of attending their high school prom a reality.
2017 CHOC Oncology Prom
The annual CHOC Oncology Prom aims to make teen cancer patients’ dreams of attending their high school prom a reality.
Oncology Referrals
How to refer to pediatric oncology cancer, Hyundai Cancer Institute, CHOC, Orange County
Donation Recognizes Unique Challenges Of Teen Oncology Patients
Our junior high, high school and college memories shape who we become. The adolescent and the teen years are typically filled with a combination of promise and and discovery.
Your child’s stay on the hematology/oncology unit
This short video will describe what you can expect during your child’s stay in the hematology and oncology unit at CHOC.
5 Things You Should Know About Oncofertility
Here are five things you may not know about Oncofertility. Cancer and its treatment have the ability to affect a person's experience of sexuality from mild to debilitating in psychosocial and physiological ways.
RXDX-101-03 – A Phase 1/1b, Open-Label, Dose-Escalation and Expansion Study of Entrectinib (RXDX-101) in Children and Adolescents with Recurrent or Refractory Solid Tumors and Primary CNS Tumors, with or without TRK, ROS1, or ALK Fusions (Igny
Clinical Trial Protocol # RXDX 101 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Adolescent and Young Adult (AYA) Treatment Program at CHOC
Learn about CHOC's Adolescent and Young Adult (AYA) Program from a former oncology patient and a pediatric oncologist and medical director.
Sato, Mariko MD
Dr. Sato is a board certified pediatric oncologist at CHOC Hospital in Orange County.
Selena Gomez Delights Fans at Children’s Hospital of Orange County Prom
The singer made an appearance on Saturday night at the Children’s Hospital Orange County’s oncology prom event.
Selena Gomez and more stars surprise Children’s Hospital teen patients at their annual prom event
The Children's Hospital of Orange County’s oncology prom became a star-studded affair when celebrities like Selena Gomez made surprise appearances.
Selena Gomez Spends Time With Fans at Children’s Hospital of O.C. Prom Event
The 25-year-old pop star made a special stop at the Children's Hospital of Orange County's oncology prom event on Saturday.
Selena Gomez Meets Fans at Children’s Hospital of Orange County Prom
Selena Gomez spent part of her Saturday making a special guest appearance at Children's Hospital Orange County's oncology prom event.
Selena Gomez, ‘Grey’s Anatomy’ cast attend prom night at children’s hospital
Jack Black, Selena Gomez, and “Grey’s Anatomy” cast members attended the 17th annual Children's Hospital of Orange County (CHOC) Oncology Prom.
Selena Gomez Surprises Fans at Hospital Prom — and Sticks Around for Selfies
Selena Gomez spent her Saturday night making a special appearance in SoCal, much to the delight of the kids she surprised.
Teens with cancer attend 16th annual hospital prom at CHOC
CHOC celebrated its 16th annual oncology prom with an “Alice in Wonderland” theme for about 250 cancer patients and guests on Saturday night, June 24.
Williams, Venita L. MD
Dr. Venita Williams is a board certified radiation oncologist who treats kids and adolescents with cancer.
Pathare, Jody NP
Jody Pathare is a nurse practitioner who specializes in oncology medicine. She provides care for kids and teens with cancer at CHOC.
ADVL1515 A Phase 1 Study of LY2606368, a CHK1/2 Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors
Clinical Trial Protocol # ADVL1515 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
ADVL1615, A Phase 1 Study of Pevonedistat (MLN4924, IND# 136078), a NEDD8 Activating Enzyme (NAE) Inhibitor, in Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1615 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
ADVL1513, A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors and Lymphoma
Clinical Trial Protocol # ADVL1513 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Phase I/IIa, 2-Part, Multi-Center, Single-Arm, Open-Label Study to Determine the Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib in Pediatric Subjects Aged 1 Month to < 18 Years with Advance BRAF V600-Mutation Positive Solid Tumors
Clinical Trial Protocol # GSK Dabrafenib | Brain Tumor/ Centra Nervous System/Neuro-Oncology, Solid Tumors | Contact (714) 509-8646
ACNS1422 A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Clinical Trial Protocol # ACNS1422 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
Clinical Trial Protocol # Head Start IV | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
